1. Home
  2. CDE vs DGX Comparison

CDE vs DGX Comparison

Compare CDE & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coeur Mining Inc.

CDE

Coeur Mining Inc.

HOLD

Current Price

$19.22

Market Cap

18.3B

ML Signal

HOLD

Logo Quest Diagnostics Incorporated

DGX

Quest Diagnostics Incorporated

HOLD

Current Price

$195.42

Market Cap

21.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDE
DGX
Founded
1928
1967
Country
United States
United States
Employees
N/A
N/A
Industry
Precious Metals
Medical Specialities
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.3B
21.0B
IPO Year
1994
1996

Fundamental Metrics

Financial Performance
Metric
CDE
DGX
Price
$19.22
$195.42
Analyst Decision
Strong Buy
Buy
Analyst Count
5
13
Target Price
$22.40
$214.38
AVG Volume (30 Days)
17.1M
635.0K
Earning Date
05-06-2026
04-21-2026
Dividend Yield
N/A
1.82%
EPS Growth
533.33
13.78
EPS
0.35
2.24
Revenue
$709,598,000.00
$11,035,000,000.00
Revenue This Year
$165.39
$7.53
Revenue Next Year
$12.10
$3.77
P/E Ratio
$53.19
$87.84
Revenue Growth
N/A
11.78
52 Week Low
$8.26
$164.65
52 Week High
$27.77
$213.50

Technical Indicators

Market Signals
Indicator
CDE
DGX
Relative Strength Index (RSI) 53.74 55.29
Support Level $19.08 $191.75
Resistance Level $20.06 $200.49
Average True Range (ATR) 0.93 3.64
MACD 0.11 0.86
Stochastic Oscillator 66.45 83.27

Price Performance

Historical Comparison
CDE
DGX

About CDE Coeur Mining Inc.

Coeur Mining Inc is a metals producer focused on mining precious minerals in the Americas. It is involved in the discovery and mining of gold and silver and generates the vast majority of revenue from the sale of these precious metals. The operating mines of the company are palmarejo, Rochester, Wharf, and Kensington. Its projects are located in the United States, Canada, and Mexico generating maximum revenue from United States.

About DGX Quest Diagnostics Incorporated

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Share on Social Networks: